• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

VP-16-213 versus polychemotherapy in patients with advanced small cell lung cancer.

作者信息

Eagan R T, Carr D T, Frytak S, Rubin J, Lee R E

出版信息

Cancer Treat Rep. 1976 Jul;60(7):949-51.

PMID:64298
Abstract
摘要

相似文献

1
VP-16-213 versus polychemotherapy in patients with advanced small cell lung cancer.
Cancer Treat Rep. 1976 Jul;60(7):949-51.
2
[VP 16-213 in combination with endoxan, methotrexate and oncovin as polychemotherapy for bronchogenic carcinoma].
Schweiz Med Wochenschr. 1977 Jul 2;107(26):912-5.
3
VP-16 in combinations for first-line treatment of malignant germ-cell tumors and gestational choriocarcinoma.依托泊苷联合用药用于恶性生殖细胞肿瘤和妊娠性绒毛膜癌的一线治疗。
Semin Oncol. 1985 Mar;12(1 Suppl 2):37-41.
4
ICRF-159 versus polychemotherapy in non-small cell lung cancer.ICRF - 159与多药化疗治疗非小细胞肺癌的对比
Cancer Treat Rep. 1976 Jul;60(7):947-8.
5
Phase II trial of etoposide, vincristine, and high-dose cisplatin in advanced non-small cell lung cancer.依托泊苷、长春新碱和高剂量顺铂治疗晚期非小细胞肺癌的II期试验
Cancer Treat Rep. 1985 Nov;69(11):1335-6.
6
Phase II studies of polychemotherapy regimens in small cell lung cancer.小细胞肺癌多药化疗方案的II期研究。
Cancer Treat Rep. 1977 Jan-Feb;61(1):93-5.
7
VP-16-213 in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone in the treatment of non-Hodgkin's lymphomas.依托泊苷（VP - 16 - 213）联合环磷酰胺、阿霉素、长春新碱及强的松治疗非霍奇金淋巴瘤。
Cancer Treat Rep. 1980 Oct-Nov;64(10-11):1135-7.
8
Cyclophosphamide and VP-16-213 with or without cisplatin in squamous cell and small cell lung cancers.环磷酰胺和依托泊苷联合或不联合顺铂用于治疗鳞状细胞癌和小细胞肺癌。
Cancer Treat Rep. 1981 May-Jun;65(5-6):453-8.
9
VP-16-213 therapy in patients with small-cell carcinoma of the lung after failure on combination chemotherapy.在联合化疗失败后，对小细胞肺癌患者进行依托泊苷（VP - 16 - 213）治疗。
Cancer Clin Trials. 1981;4(2):155-7.
10
MACC (methotrexate, doxorubicin, cyclophosphamide and lomustine) versus cis-platinum and etoposide in the treatment of advanced non-small cell lung cancer.
Chemioterapia. 1986 Feb;5(1):53-7.

引用本文的文献

1
Phase II protocol for the evaluation of new treatments in patients with advanced gastric carcinoma: results of ECOG 5282.晚期胃癌患者新治疗方法评估的II期试验方案：东部肿瘤协作组（ECOG）5282研究结果
Med Oncol. 1999 Dec;16(4):261-6. doi: 10.1007/BF02785872.
2
Etoposide: current status and future perspectives in the management of malignant neoplasms.依托泊苷：恶性肿瘤治疗的现状与未来展望
Cancer Chemother Pharmacol. 1994;34 Suppl:S118-26. doi: 10.1007/BF00684875.
3
Biodistribution of O6-benzylguanine and its effectiveness against human brain tumor xenografts when given in polyethylene glycol or cremophor-EL.
Cancer Chemother Pharmacol. 1994;35(2):121-6. doi: 10.1007/BF00686633.
4
VP16-213 (etoposide). A critical review of its activity.依托泊苷（VP16 - 213）。对其活性的批判性综述。
Cancer Chemother Pharmacol. 1982;7(2-3):81-5. doi: 10.1007/BF00254526.
5
The podophyllotoxin derivatives VP16-213 and VM26.
Cancer Chemother Pharmacol. 1982;7(2-3):73-80. doi: 10.1007/BF00254525.
6
[Etoposide VP 16--213)--a podophyllotoxinderivative with high antitumor activity (author's transl)].依托泊苷（VP 16-213）——一种具有高抗肿瘤活性的鬼臼毒素衍生物（作者译）
Klin Wochenschr. 1981 Nov 2;59(21):1177-88. doi: 10.1007/BF01721212.
7
Epipodophyllotoxin (VP16-213) in small cell carcinoma of the Bronchus resistant to initial combination chemotherapy.支气管小细胞癌中对初始联合化疗耐药的表鬼臼毒素（VP16 - 213）
Cancer Chemother Pharmacol. 1982;7(2-3):179-80. doi: 10.1007/BF00254544.
8
Clinical trial of etoposide (VP-16) in children with recurrent malignant solid tumors. A phase II study from the Pediatric Oncology Group.
Invest New Drugs. 1988 Apr;6(1):31-6. doi: 10.1007/BF00170776.
9
Etoposide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in combination chemotherapy of cancer.依托泊苷。对其药效学和药代动力学特性以及在癌症联合化疗中的治疗潜力的综述。
Drugs. 1990 Mar;39(3):438-90. doi: 10.2165/00003495-199039030-00008.
10
Podophyllotoxin derivative VP 16-213.鬼臼毒素衍生物VP 16 - 213
Cancer Chemother Pharmacol. 1979;3(2):71-80. doi: 10.1007/BF00254976.